IMAX or LYV: Which Is the Better Value Stock Right Now?

14.01.26 17:40 Uhr

Werte in diesem Artikel
Aktien

31,20 EUR 1,20 EUR 4,00%

Indizes

23.515,4 PKT -14,6 PKT -0,06%

Investors interested in Film and Television Production and Distribution stocks are likely familiar with Imax (IMAX) and Live Nation (LYV). But which of these two stocks is more attractive to value investors? We'll need to take a closer look to find out.We have found that the best way to discover great value opportunities is to pair a strong Zacks Rank with a great grade in the Value category of our Style Scores system. The proven Zacks Rank emphasizes companies with positive estimate revision trends, and our Style Scores highlight stocks with specific traits.Right now, Imax is sporting a Zacks Rank of #2 (Buy), while Live Nation has a Zacks Rank of #3 (Hold). The Zacks Rank favors stocks that have recently seen positive revisions to their earnings estimates, so investors should rest assured that IMAX has an improving earnings outlook. However, value investors will care about much more than just this.Value investors are also interested in a number of tried-and-true valuation metrics that help show when a company is undervalued at its current share price levels.Our Value category grades stocks based on a number of key metrics, including the tried-and-true P/E ratio, the P/S ratio, earnings yield, and cash flow per share, as well as a variety of other fundamentals that value investors frequently use.IMAX currently has a forward P/E ratio of 22.36, while LYV has a forward P/E of 67.72. We also note that IMAX has a PEG ratio of 1.33. This figure is similar to the commonly-used P/E ratio, with the PEG ratio also factoring in a company's expected earnings growth rate. LYV currently has a PEG ratio of 9.34.Another notable valuation metric for IMAX is its P/B ratio of 4.25. The P/B ratio is used to compare a stock's market value with its book value, which is defined as total assets minus total liabilities. For comparison, LYV has a P/B of 30.36.These are just a few of the metrics contributing to IMAX's Value grade of B and LYV's Value grade of C.IMAX stands above LYV thanks to its solid earnings outlook, and based on these valuation figures, we also feel that IMAX is the superior value option right now.Just Released: Zacks Top 10 Stocks for 2026Hurry – you can still get in early on our 10 top tickers for 2026. Handpicked by Zacks Director of Research Sheraz Mian, this portfolio has been stunningly and consistently successful.From inception in 2012 through November, 2025, the Zacks Top 10 Stocks gained +2,530.8%, more than QUADRUPLING the S&P 500’s +570.3%.Sheraz has combed through 4,400 companies covered by the Zacks Rank and handpicked the best 10 to buy and hold in 2026. You can still be among the first to see these just-released stocks with enormous potential.See New Top 10 Stocks >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report IMAX Corporation (IMAX): Free Stock Analysis Report Live Nation Entertainment, Inc. (LYV): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

Ausgewählte Hebelprodukte auf IMAX

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf IMAX

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Quelle: Zacks

Nachrichten zu IMAX Corp.

Wer­bung

Analysen zu IMAX Corp.

DatumRatingAnalyst
25.02.2019IMAX HoldCanaccord Adams
27.04.2018IMAX BuyThe Benchmark Company
28.02.2018IMAX BuyB. Riley FBR, Inc.
30.10.2017IMAX OutperformBarrington Research
12.07.2017IMAX Mkt PerformBarrington Research
DatumRatingAnalyst
27.04.2018IMAX BuyThe Benchmark Company
28.02.2018IMAX BuyB. Riley FBR, Inc.
30.10.2017IMAX OutperformBarrington Research
21.04.2017IMAX OutperformWedbush Morgan Securities Inc.
22.04.2016IMAX BuyMKM Partners
DatumRatingAnalyst
25.02.2019IMAX HoldCanaccord Adams
12.07.2017IMAX Mkt PerformBarrington Research
07.06.2017IMAX HoldThe Benchmark Company
03.05.2011IMAX holdStifel, Nicolaus & Co., Inc.
12.01.2006IMAX abwartenDer Aktionär
DatumRatingAnalyst

Keine Analysen im Zeitraum eines Jahres in dieser Kategorie verfügbar.

Eventuell finden Sie Nachrichten die älter als ein Jahr sind im Archiv

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für IMAX Corp. nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen